SCHEMBL30759674

SCHEMBL30759674

CCOC(=O)c1nn(-c2cc(Cl)cc(Cl)c2)c2c1CCc1cc(OC)c(-c3cncc(C(N)=O)c3)cc1-2

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CCNA2 P20248 6/20 0.42
▸ CDK2 P24941 6/20 0.42
▸ CCNA1 P78396 6/20 0.42
▸ RAD52 P43351 1/20 0.37
▸ KCNK3 O14649 1/20 0.36
▸ IKBKB O14920 4/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ TP53 P04637 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MAPT P10636 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27120495 1.00 CCNA2 (0.42) CCNA2CDK2CCNA1RAD52KCNK3
SCHEMBL30759553 0.90 CCNA2 (0.38) CCNA2CDK2CCNA1RAD52IKBKB
SCHEMBL27119960 0.90 CCNA2 (0.38) CCNA2CDK2CCNA1RAD52IKBKB
SCHEMBL27122153 0.89 RAD52 (0.40) CCNA2CDK2CCNA1RAD52IKBKB
SCHEMBL27120632 0.88 RAD52 (0.39) CCNA2CDK2CCNA1RAD52IKBKB
SCHEMBL27122870 0.87 RAD52 (0.36) CCNA2CDK2CCNA1RAD52IKBKB
SCHEMBL27122203 0.86 RAD52 (0.38) CCNA2CDK2CCNA1RAD52IKBKB
SCHEMBL27122184 0.86 IKBKB (0.36) CCNA2CDK2CCNA1RAD52IKBKB
SCHEMBL30759625 0.85 PDE7A (0.36) CCNA2CDK2CCNA1RAD52IKBKB
SCHEMBL27119776 0.85 PDE7A (0.36) CCNA2CDK2CCNA1RAD52IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577206-A2 NOVEL MODULATORS OF FSHR AND USES THEREOF Celmatix Inc. (US) 2025-07-02 — — EP disclosed
WO-2024044778-A2 NOVEL MODULATORS OF FSHR AND USES THEREOF CELMATIX INC. (US) 2024-02-29 — — WO disclosed
Send feedback